The article presents a critique of the Doha Paragraph 6 System and challenges its effectualness as a real panacea to the global access to medicines conundrum.The article posits that without the ability to manufacture pharmaceuticals locally, the TRIPS compulsory licensing regime in the long term offers no significant advantage to the world's most vulnerable populations
This article provides the first comprehensive analysis of when compulsory licensing of patents is pe...
The public health flexibility of compulsory licensing of patents, originally provided under article ...
The World Health Organization has once declared antiretroviral therapy a state of global emergency. ...
The article presents a critique of the Doha Paragraph 6 System and challenges its effectualness as a...
357-363While the TRIPS Agreement provides for the patenting of drugs, it also provides for compulso...
This article critically analyzes the agreement implementing Paragraph 6 of the Doha Declaration. The...
The Agreement on Trade-Related Aspects of Intellectual Property (TRIPS) is one of the cornerstones o...
The purpose of this article is to analyse how developments after the Doha Declaration went wrong; ho...
In response to concerns that patent protection for pharmaceuticals negatively affected world health,...
The World Trade Organization ( WTO ) Trade-Related Aspects of Intellectual Property Rights Agreement...
The purpose of this article is to analyse how developments after the Doha Declaration went wrong; ho...
401-413Adhering to the TRIPS Agreement in the pharmaceutical sector poses several questions before d...
This entry into force of the World Trade Organization (WTO) TRIPS Agreement in 1995 transformed the ...
The conflict between patents and public health has been a long-standing concern. The current COVID-1...
Startling numbers of people die every day because they do not have access to essential medicines and...
This article provides the first comprehensive analysis of when compulsory licensing of patents is pe...
The public health flexibility of compulsory licensing of patents, originally provided under article ...
The World Health Organization has once declared antiretroviral therapy a state of global emergency. ...
The article presents a critique of the Doha Paragraph 6 System and challenges its effectualness as a...
357-363While the TRIPS Agreement provides for the patenting of drugs, it also provides for compulso...
This article critically analyzes the agreement implementing Paragraph 6 of the Doha Declaration. The...
The Agreement on Trade-Related Aspects of Intellectual Property (TRIPS) is one of the cornerstones o...
The purpose of this article is to analyse how developments after the Doha Declaration went wrong; ho...
In response to concerns that patent protection for pharmaceuticals negatively affected world health,...
The World Trade Organization ( WTO ) Trade-Related Aspects of Intellectual Property Rights Agreement...
The purpose of this article is to analyse how developments after the Doha Declaration went wrong; ho...
401-413Adhering to the TRIPS Agreement in the pharmaceutical sector poses several questions before d...
This entry into force of the World Trade Organization (WTO) TRIPS Agreement in 1995 transformed the ...
The conflict between patents and public health has been a long-standing concern. The current COVID-1...
Startling numbers of people die every day because they do not have access to essential medicines and...
This article provides the first comprehensive analysis of when compulsory licensing of patents is pe...
The public health flexibility of compulsory licensing of patents, originally provided under article ...
The World Health Organization has once declared antiretroviral therapy a state of global emergency. ...